Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate to severe atopic dermatitis after it failed to meet efficacy goals in an interim analysis. … Read more
A logo on the Sanofi exhibition space at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris, France, on June 15, 2022. Benoit Tessier | Reuters Sanofi said on Wednesday it will buy U.S. biotech Dynavax Technologies for around $2.2 billion (1.9 billion euros) in an agreed deal that … Read more
LONDON — European markets edged into positive territory on Wednesday as investors take stock of the volatile year during Christmas Eve’s shortened trading session. The pan-European Stoxx 600 was just above the flatline at 9:25 a.m. in London (4:25 a.m. ET). The benchmark reached a new record closing high on Tuesday, buoyed by Copenhagen-listed Novo Nordisk’s … Read more
U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White House December 19, 2025 in Washington, DC. Trump delivered remarks on lowering prescription drug prices during the event. Alex Wong | Getty Images Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump on Friday to … Read more